Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06725290

Dry Eye Disease With Isotretinoin ISOTRETINOIN

Digital Assessment of Dry Eye Diseases in Acne Vulgaris Patients Receiving Isotretinoin Therapy

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The study aims to explore the effects of isotretinoin therapy on the dry eye parameters in acne vulgaris patients \& determine if it is dose-dependent or not.

Detailed description

To measure the tear film, the eye lid thickness, the meibomian gland function and to do objective tests for comparison

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOcular Surface Disease Index (OSDI) questionnaireThe OSDI is a validated, self-administered questionnaire for assessing the presence and severity of ocular surface disease symptoms. The OSDI questionnaire includes 12 questions about the respondent's past week experience with the ocular symptoms, vision-related function, and environmental triggers

Timeline

Start date
2025-06-01
Primary completion
2025-08-01
Completion
2025-09-30
First posted
2024-12-10
Last updated
2025-05-14

Source: ClinicalTrials.gov record NCT06725290. Inclusion in this directory is not an endorsement.

Dry Eye Disease With Isotretinoin ISOTRETINOIN (NCT06725290) · Clinical Trials Directory